We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Starbucks
SBUX
$118B
| $86.1M | 0.19% |
1,021,283
+549,004
| +116% | +$46.6M |
|
102
PepsiCo
PEP
$186B
| $86M | 0.19% |
527,018
-467,383
| -47% | -$80.5M |
|
103
Paycom
PAYC
$6.78B
| $85.5M | 0.19% |
259,108
-79,984
| -24% | -$27.5M |
|
104
Albertsons Companies
ACI
$5.4B
| $84.6M | 0.19% |
+3,404,097
| New | +$92.9M |
|
|
SF
105
Stifel
SF
$12.3B
| $84.3M | 0.18% |
2,436,443
-30,729
| -1% | -$1.21M |
|
|
MPT
106
Medical Properties Trust
MPT
$2.89B
| $84.3M | 0.18% |
7,104,051
+5,521,226
| +349% | +$83.6M |
|
107
Cardinal Health
CAH
$53.4B
| $84M | 0.18% |
1,259,640
+1,240,180
| +6,373% | +$78.6M |
|
108
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $82.9M | 0.18% |
1,161,700
+254,400
| +28% | +$19.2M |
|
109
Paychex
PAYX
$40.4B
| $82.8M | 0.18% |
737,904
+510,432
| +224% | +$63.3M |
|
110
Lumen
LUMN
$6.53B
| $81.9M | 0.18% |
11,249,889
+1,424,492
| +14% | +$14.5M |
|
111
McDonald's
MCD
$188B
| $80.3M | 0.18% |
347,882
-333,008
| -49% | -$85.1M |
|
112
SM Energy
SM
$7.96B
| $79.8M | 0.17% |
2,121,523
-242,191
| -10% | -$9.53M |
|
113
Estee Lauder
EL
$29B
| $79.7M | 0.17% |
369,018
-488,347
| -57% | -$125M |
|
|
P
114
Everpure Inc
P
$24.8B
| $79.6M | 0.17% |
2,909,720
+1,394,660
| +92% | +$39.4M |
|
115
Clean Harbors
CLH
$16.1B
| $79.6M | 0.17% |
723,734
-165,173
| -19% | -$17.7M |
|
116
Vertex Pharmaceuticals
VRTX
$121B
| $79.3M | 0.17% |
273,852
-117,300
| -30% | -$33.7M |
|
117
Moderna
MRNA
$21.5B
| $79.3M | 0.17% |
670,301
+44,546
| +7% | +$6.76M |
|
118
CoStar Group
CSGP
$11.3B
| $78.6M | 0.17% |
1,128,518
+196,037
| +21% | +$13.6M |
|
119
Northrop Grumman
NOC
$77B
| $78.5M | 0.17% |
166,926
+64,594
| +63% | +$30.8M |
|
|
IAA
120
DELISTED
IAA, Inc. Common Stock
IAA
| $78M | 0.17% |
2,447,956
-253,920
| -9% | -$9.01M |
|
121
NVIDIA
NVDA
$5.01T
| $77.8M | 0.17% |
6,406,670
-691,100
| -10% | -$10.9M |
|
122
Copa Holdings
CPA
$5.56B
| $77.4M | 0.17% |
1,155,174
-228,255
| -16% | -$15.9M |
|
123
SPDR Gold Trust
GLD
$131B
| $77.1M | 0.17% |
498,279
+247,086
| +98% | +$39.7M |
|
124
Fastenal
FAST
$54B
| $76.6M | 0.17% |
3,327,286
+3,089,300
| +1,298% | +$77.9M |
|
125
IQVIA
IQV
$34.7B
| $75.7M | 0.17% |
417,789
+355,482
| +571% | +$77.9M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.